Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.

Novo Nordisk (NVO) stock falls after issuing weak outlook for 2026 due to pricing pressure and competition. Q4 earnings beat.

Leaders of federally qualified clinics and safety-net hospitals joined local politicians to highlight what they say is a ...

Henry Ford Health, one of Michigan’s largest 340B health systems, spent $90 million on a naming and branding partnership with ...

Community health centers that primarily serve low-income patients fear Gov. Bob Ferguson's proposed supplemental budget will hamper their ability to pa ...

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

A federal judge has issued a preliminary injunction halting the Department of Health and Human Services’ (HHS) 340B Rebate Model Pilot Program, which was scheduled to take effect on January 1, 2026.

After federal judges blocked HHS’ 340B rebate pilot program from taking effect Jan. 1, HHS is discussing whether to reconsider the drug manufacturers’ plans, according to court documents. On Jan. 7, ...

The Department of Health and Human Services appears willing to take its contentious 340B Rebate Model Pilot Model back to the drawing board. After a lawsuit filed by hospitals secured a last-minute ...

The US Department of Health and Human Services is negotiating with hospital groups about reconsidering a new drug rebate pilot that was scheduled to take effect Jan. 1, according to filings in a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...